Dirceu Barbano confirmed as head of Anvisa in Brazil
This article was originally published in SRA
Dirceu Br�s Aparecido Barbano has been confirmed as director-president of the Brazilian healthcare products regulatory agency Anvisa (Agência Nacional de Vigilância Sanit�ria). He has held this role in a caretaker capacity since January, when his predecessor, clinical analyst Dirceu Raposo de Mello, stepped down after six years at the helm. Mr Barbano joined the Brasilia-based agency as a director in October 2008, with a background specialising in pharmacy.
You may also be interested in...
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.
Keeping Track: Oncology Submissions From Blueprint, Y-mAbs, BMS/bluebird; Approvals For BMS’ Reblozyl, LFB’s SevenFact
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker.
Temporary policy may open door to longer term change as Medicare allows reimbursement of at-home administration of non-hospital drugs covered by Part B under a recently-released regulation aiding at encouraging telehealth during the coronavirus outbreak.